“This vaccine is authorized for emergency use in persons age 16 years and older. This is a two-dose vaccine, given 21 days apart. Clinical trial data show the vaccine is 95% effective at preventing COVID-19 infection starting 7 days after the 2nd dose. Individual will not be considered fully protected until 2 weeks after the y receive the 2nd dose. The clinical trials revealed no major unanticipated adverse events. This vaccine arrived in Washington (state) on December 14th.”
-Washington State Department of Health
